Categorical Change in T2 Lesion Volume and Clinical Outcomes in the Phase III Freedoms and its Extension Study, Evaluating Fingolimod in Patients With Relapsing-Remitting Multiple Sclerosis

D. Jeffery, E. V. D. Cantogno, D. P. Meier, M. Meinel, P. Chin, A. Shamim, France, USA, Switzerland